{"id":"placebo-for-duloxetine","safety":{"commonSideEffects":[{"rate":"typically 20–40% depending on condition and trial design","effect":"Placebo effect (symptom improvement unrelated to pharmacology)"}]},"_chembl":{"chemblId":"CHEMBL1200328","moleculeType":"Small molecule","molecularWeight":"333.88"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is a non-active substance used in randomized controlled trials to establish a baseline for comparison against active drug treatment. Any clinical benefit observed with placebo is attributed to the placebo effect—a psychobiological response driven by patient expectation, therapeutic context, and natural disease progression. This allows researchers to isolate the true pharmacological efficacy of the active comparator drug (in this case, Duloxetine).","oneSentence":"Placebo produces no pharmacological effect and serves as an inert control in clinical trials to measure the baseline therapeutic response independent of drug action.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:51.553Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Duloxetine clinical trials (depression, anxiety, chronic pain, fibromyalgia, diabetic peripheral neuropathic pain)"}]},"trialDetails":[{"nctId":"NCT07498140","phase":"NA","title":"Procedural Framing and Epidural Steroid Injection Outcomes","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2026-03-25","conditions":"Lumbosacral Radiculopathy","enrollment":210},{"nctId":"NCT07495943","phase":"NA","title":"Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia","status":"NOT_YET_RECRUITING","sponsor":"Haydarpasa Numune Training and Research Hospital","startDate":"2026-05-04","conditions":"Fibromyalgia Syndrome, Fibromyalgia","enrollment":200},{"nctId":"NCT06807866","phase":"PHASE4","title":"Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-03-01","conditions":"THA","enrollment":64},{"nctId":"NCT07421427","phase":"NA","title":"Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02-21","conditions":"Amantadine, Duloxetine, Pregabalin","enrollment":150},{"nctId":"NCT05110144","phase":"PHASE2","title":"Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-11-01","conditions":"Refractory Chronic Cough","enrollment":50},{"nctId":"NCT05120934","phase":"PHASE2","title":"Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-11-01","conditions":"Interstitial Lung Disease","enrollment":25},{"nctId":"NCT06837857","phase":"PHASE2","title":"Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-04-16","conditions":"Pain, Chronic","enrollment":200},{"nctId":"NCT07203339","phase":"NA","title":"Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)","status":"RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2025-09-30","conditions":"Fibromyalgia (FM), tDCS, Duloxetine","enrollment":610},{"nctId":"NCT06423716","phase":"PHASE4","title":"Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE)","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-11-01","conditions":"Knee Osteoarthritis","enrollment":150},{"nctId":"NCT06614322","phase":"PHASE2","title":"SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-01","conditions":"Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":190},{"nctId":"NCT05311774","phase":"NA","title":"Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-04-01","conditions":"Cancer Pain","enrollment":400},{"nctId":"NCT05851976","phase":"PHASE4","title":"Duloxetine for LBP","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2023-10-04","conditions":"Back Pain, Low","enrollment":120},{"nctId":"NCT06842992","phase":"PHASE2","title":"A Phase II Study to Evaluate NH102 for Depression","status":"COMPLETED","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2024-12-04","conditions":"Major Depressive Disorder (MDD)","enrollment":243},{"nctId":"NCT06259526","phase":"PHASE2","title":"A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2023-12-26","conditions":"Depression","enrollment":267},{"nctId":"NCT05086393","phase":"PHASE4","title":"Duloxetine RCT on Postop TKA Outcomes","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2021-11-01","conditions":"Pain, Postoperative, Total Knee Arthroplasty","enrollment":241},{"nctId":"NCT06591091","phase":"PHASE2","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09","conditions":"Depression","enrollment":80},{"nctId":"NCT07120880","phase":"PHASE3","title":"Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Major Depressive Disorder (MDD) With Insomnia","enrollment":184},{"nctId":"NCT05611749","phase":"PHASE2","title":"Duloxetine Impact on Postoperative Pain Control and Outcomes","status":"TERMINATED","sponsor":"Scripps Health","startDate":"2023-05-30","conditions":"Acute Post-operative Pain, Chronic Post Operative Pain, Narcotic Use","enrollment":17},{"nctId":"NCT02417064","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-10","conditions":"Treatment-resistant Depression","enrollment":346},{"nctId":"NCT03434041","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-25","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":252},{"nctId":"NCT02493868","phase":"PHASE3","title":"A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-10-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":719},{"nctId":"NCT02418585","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-07","conditions":"Treatment-resistant Depression","enrollment":236},{"nctId":"NCT02422186","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-20","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":139},{"nctId":"NCT03321526","phase":"PHASE2","title":"A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-12-12","conditions":"Depressive Disorder, Major","enrollment":107},{"nctId":"NCT03852160","phase":"PHASE3","title":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen-Cilag International NV","startDate":"2019-12-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":""},{"nctId":"NCT03575403","phase":"PHASE1","title":"Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)","status":"COMPLETED","sponsor":"Craig Rush","startDate":"2018-09-01","conditions":"Alcohol Use Disorder","enrollment":19},{"nctId":"NCT05786599","phase":"PHASE2, PHASE3","title":"Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-03-21","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":50},{"nctId":"NCT03271151","phase":"PHASE4","title":"Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-09-28","conditions":"Joint Disease, Pain, Acute, Pain, Chronic","enrollment":160},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT03249558","phase":"PHASE4","title":"Effect of Combined Morphine and Duloxetine on Chronic Pain","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-03-12","conditions":"Chronic Low Back Pain, Chronic Neck Pain","enrollment":81},{"nctId":"NCT03797560","phase":"NA","title":"Comparison of Ba-Duan-Jin and Pregabalin in Patients with Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-03-22","conditions":"Fibromyalgia","enrollment":104},{"nctId":"NCT03890133","phase":"NA","title":"Exploration the Mechanism of Ba-Duan-Jin Therapy in the Management of Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-04-01","conditions":"Fibromyalgia","enrollment":60},{"nctId":"NCT06606067","phase":"PHASE3","title":"Duloxetine to Prevent Chronic Postsurgical Pain After Inguinal Hernia Repair in Patients at High Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2024-09-03","conditions":"Chronic Post-surgical Pain","enrollment":294},{"nctId":"NCT00200902","phase":"PHASE4","title":"Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2005-08","conditions":"Depression","enrollment":88},{"nctId":"NCT06232473","phase":"PHASE4","title":"Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-01-01","conditions":"Functional Disorder","enrollment":424},{"nctId":"NCT02229825","phase":"PHASE4","title":"Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2007-02-09","conditions":"Depressive Disorder, Major","enrollment":339},{"nctId":"NCT03538691","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2018-07-13","conditions":"Major Depressive Disorder","enrollment":1149},{"nctId":"NCT02058693","phase":"PHASE4","title":"Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2010-12","conditions":"Major Depressive Disorder","enrollment":41},{"nctId":"NCT03068247","phase":"PHASE3","title":"Neurobiology of Treatment Responses in MDD","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2021-11","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT04836533","phase":"PHASE1","title":"Enhancing Processing Speed and Executive Functioning in Depressed Older Adults With Computerized Cognitive Training","status":"WITHDRAWN","sponsor":"Queens College, The City University of New York","startDate":"2023-01-31","conditions":"Depression in Old Age, Depression","enrollment":""},{"nctId":"NCT05711810","phase":"PHASE4","title":"Medicine-induced Cardiac Hemodialysis on COVID-19","status":"COMPLETED","sponsor":"Yang I. Pachankis","startDate":"2023-01-02","conditions":"Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines","enrollment":1},{"nctId":"NCT04178993","phase":"PHASE1","title":"Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]","status":"COMPLETED","sponsor":"Craig Rush","startDate":"2019-09-01","conditions":"Methamphetamine Use Disorder","enrollment":8},{"nctId":"NCT01598298","phase":"PHASE3","title":"S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2013-05-15","conditions":"Breast Cancer, Musculoskeletal Complications, Pain","enrollment":299},{"nctId":"NCT04639011","phase":"PHASE4","title":"Duloxetine Tibial Plateau","status":"WITHDRAWN","sponsor":"Boston Medical Center","startDate":"2022-10","conditions":"Tibial Plateau Fracture, Pain, Postoperative","enrollment":""},{"nctId":"NCT05115123","phase":"PHASE2","title":"Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2022-03-02","conditions":"Pain, Postoperative","enrollment":60},{"nctId":"NCT04965272","phase":"PHASE2","title":"A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone","status":"WITHDRAWN","sponsor":"AbbVie","startDate":"2021-08-18","conditions":"Generalized Anxiety Disorder","enrollment":""},{"nctId":"NCT04224584","phase":"PHASE2","title":"A Mechanism Based Proof of Concept Study of the Effects of Duloxetine in the Treatment of Patients With Osteoarthritic Knee Pain","status":"COMPLETED","sponsor":"Kristian Kjær Petersen","startDate":"2020-01-01","conditions":"Osteoarthritis, Knee","enrollment":40},{"nctId":"NCT04364997","phase":"PHASE3","title":"Study of Desvenlafaxine in Treating Major Depressive Disorder.","status":"COMPLETED","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2020-06-18","conditions":"Major Depressive Disorder","enrollment":420},{"nctId":"NCT00863057","phase":"PHASE2","title":"Combination Pain Therapy in HIV Neuropathy","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-05","conditions":"HIV Infections, Peripheral Neuropathy","enrollment":15},{"nctId":"NCT05050656","phase":"PHASE4","title":"Oral Duloxetine as a Premedication for Postoperative Pain Control","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-03-15","conditions":"Anesthesia","enrollment":70},{"nctId":"NCT01436162","phase":"PHASE3","title":"Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Shire","startDate":"2011-10-19","conditions":"Major Depressive Disorder","enrollment":1105},{"nctId":"NCT01436149","phase":"PHASE3","title":"Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Shire","startDate":"2011-10-27","conditions":"Major Depressive Disorder","enrollment":1262},{"nctId":"NCT00981149","phase":"NA","title":"Duloxetine for Treatment of Painful Temporomandibular Joint Disorder","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2009-05","conditions":"Temporomandibular Joint Disorders","enrollment":24},{"nctId":"NCT03276689","phase":"NA","title":"'Fix the Dysfunction' Concept for Mechanism-based Pharmacological Treatment of Neuropathic Pain by Drug","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2017-10-19","conditions":"Neuropathic Pain","enrollment":300},{"nctId":"NCT01846182","phase":"PHASE2","title":"Research Examining Gulf War Illness in Our Nations Service Members","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2015-06-24","conditions":"Gulf War Illness","enrollment":112},{"nctId":"NCT03037073","phase":"PHASE2, PHASE3","title":"Duloxetine for Succinylcholine-induced Postoperative Myalgia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-04-15","conditions":"Postoperative Myalgia","enrollment":70},{"nctId":"NCT03315533","phase":"PHASE2","title":"Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2018-01-19","conditions":"Musculoskeletal Pain","enrollment":76},{"nctId":"NCT03468348","phase":"NA","title":"Duloxetine for Acute Post-mastectomy Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2018-04-01","conditions":"Acute Pain","enrollment":88},{"nctId":"NCT03038867","phase":"PHASE2","title":"Impact of Duloxetine on Male Fertility","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2016-12-12","conditions":"Infertility, Male, Depression","enrollment":69},{"nctId":"NCT02248480","phase":"PHASE3","title":"A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-10","conditions":"Osteoarthritis of the Knee","enrollment":354},{"nctId":"NCT01451606","phase":"PHASE4","title":"Duloxetine for the Treatment of Chronic Pelvic Pain","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2011-07-11","conditions":"Pelvis Pain Chronic","enrollment":34},{"nctId":"NCT01237587","phase":"PHASE3","title":"A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-03","conditions":"Fibromyalgia","enrollment":184},{"nctId":"NCT02417935","phase":"PHASE4","title":"A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2015-04","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":304},{"nctId":"NCT03623711","phase":"EARLY_PHASE1","title":"A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression","status":"UNKNOWN","sponsor":"Yuqi Cheng","startDate":"2018-08-01","conditions":"Major Depressive Disorder, Depression, Unipolar","enrollment":200},{"nctId":"NCT01715805","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-11-15","conditions":"Major Depressive Disorder","enrollment":1022},{"nctId":"NCT01470352","phase":"NA","title":"Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention","status":"COMPLETED","sponsor":"d_yarnitsky","startDate":"2011-11-16","conditions":"Migraine","enrollment":179},{"nctId":"NCT03880916","phase":"NA","title":"Effects of Duloxetine on Postoperative Wound Complication of Total Knee Arthroplasty (TKA) in Central Sensitization Patients","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2019-03-30","conditions":"Osteoarthritis, Knee","enrollment":80},{"nctId":"NCT03249168","phase":"PHASE3","title":"Duloxetine for Post Laparoscopic Shoulder Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-10-01","conditions":"Post Laparoscopic Shoulder Pain","enrollment":60},{"nctId":"NCT00854100","phase":"PHASE2","title":"Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2009-06-30","conditions":"Major Depressive Disorder","enrollment":231},{"nctId":"NCT02590874","phase":"PHASE4","title":"The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment","status":"COMPLETED","sponsor":"University of North Texas Health Science Center","startDate":"2016-01","conditions":"Mild Cognitive Impairment, Depression","enrollment":19},{"nctId":"NCT00619983","phase":"PHASE4","title":"Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy","status":"TERMINATED","sponsor":"Wake Forest University","startDate":"2008-02","conditions":"Diabetic Neuropathic Pain, Chronic Low Back Pain","enrollment":22},{"nctId":"NCT03364075","phase":"PHASE2","title":"Genetic Variants Associated With Low Back Pain and Their Response to Treatment With Duloxetine or Propranolol","status":"TERMINATED","sponsor":"Mark Ware","startDate":"2017-09-01","conditions":"Low Back Pain","enrollment":10},{"nctId":"NCT02700711","phase":"PHASE1","title":"Methylphenidate-Duloxetine Combinations for Cocaine Dependence","status":"COMPLETED","sponsor":"University of Kentucky","startDate":"2016-02","conditions":"Cocaine Use Disorder","enrollment":13},{"nctId":"NCT03350334","phase":"NA","title":"Perioperative Duloxetine for Pain Management After Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"Acibadem University","startDate":"2017-12-04","conditions":"Laparoscopic Hysterectomy, Postoperative Recovery, Postoperative Pain","enrollment":100},{"nctId":"NCT01469377","phase":"PHASE2","title":"Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2011-12-15","conditions":"Major Depressive Disorder","enrollment":819},{"nctId":"NCT02208778","phase":"PHASE4","title":"Imaging Pain Relief in Osteoarthritis","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2014-12","conditions":"Osteoarthritis, Chronic Pain","enrollment":77},{"nctId":"NCT01363284","phase":"NA","title":"Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2010-06","conditions":"Diabetes, Painful Neuropathy","enrollment":51},{"nctId":"NCT02672202","phase":"NA","title":"Shifting Pain Modulation From Pro-to Anti-nociceptive","status":"TERMINATED","sponsor":"Rambam Health Care Campus","startDate":"2016-02","conditions":"Post-operative Chronic Pain","enrollment":9},{"nctId":"NCT00849901","phase":"PHASE3","title":"A Study in the Treatment of Children and Adolescents With Major Depressive Disorder","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-03","conditions":"Major Depressive Disorder","enrollment":337},{"nctId":"NCT00360724","phase":"PHASE4","title":"Duloxetine for Chronic Depression: a Double-blind Study","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2006-08","conditions":"Dysthymic Disorder, Depressive Disorder NOS","enrollment":65},{"nctId":"NCT03250494","phase":"PHASE4","title":"Duloxetine and Dexamethasone for Improving Postoperative Pain","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2014-12","conditions":"Post Operative Pain Control","enrollment":75},{"nctId":"NCT00387413","phase":"PHASE1","title":"A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-10-02","conditions":"Hyperalgesia","enrollment":40},{"nctId":"NCT00929344","phase":"PHASE2","title":"Duloxetine Versus Pregabalin for Alcohol Dependence","status":"COMPLETED","sponsor":"The Scripps Research Institute","startDate":"2009-07","conditions":"Alcohol Dependence","enrollment":150},{"nctId":"NCT00489411","phase":"PHASE3","title":"Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2008-04","conditions":"Neurotoxicity, Pain, Peripheral Neuropathy","enrollment":231},{"nctId":"NCT02903238","phase":"NA","title":"Brain Morphometry in OA Patients Treated With Duloxetine","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2011-07","conditions":"Pain, Osteoarthritis","enrollment":21},{"nctId":"NCT00599911","phase":"PHASE2","title":"Dose-finding Study With Lu AA24530 in Major Depressive Disorder","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2007-10","conditions":"Major Depressive Disorder","enrollment":652},{"nctId":"NCT02476136","phase":"","title":"Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis","status":"UNKNOWN","sponsor":"prof. Peter de Jonge","startDate":"2015-05","conditions":"Anxiety Disorders, Panic Disorder, Obsessive-compulsive Disorder","enrollment":8800},{"nctId":"NCT01931475","phase":"PHASE3","title":"A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-09","conditions":"Osteoarthritis","enrollment":407},{"nctId":"NCT02443194","phase":"PHASE3","title":"The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients","status":"TERMINATED","sponsor":"michal roll","startDate":"2015-05","conditions":"Depression","enrollment":50},{"nctId":"NCT01470339","phase":"NA","title":"Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2011-12","conditions":"Pain","enrollment":200},{"nctId":"NCT00375973","phase":"PHASE2, PHASE3","title":"Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2006-09","conditions":"Fatigue Syndrome, Chronic","enrollment":60},{"nctId":"NCT01855919","phase":"PHASE3","title":"A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-05","conditions":"Back Pain Lower Back Chronic","enrollment":458},{"nctId":"NCT00603265","phase":"PHASE2","title":"Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2007-11","conditions":"Peripheral Neuropathy, Neuropathic Pain","enrollment":226},{"nctId":"NCT00457730","phase":"PHASE2, PHASE3","title":"A Study to Test the Use of Duloxetine for Pain in MS","status":"COMPLETED","sponsor":"Brown, Theodore R., M.D., MPH","startDate":"2007-01","conditions":"Multiple Sclerosis","enrollment":38},{"nctId":"NCT01564862","phase":"PHASE2","title":"Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-04","conditions":"Depressive Disorder, Major","enrollment":602},{"nctId":"NCT01552057","phase":"PHASE3","title":"A Study of Duloxetine in Fibromyalgia","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-03","conditions":"Fibromyalgia","enrollment":393},{"nctId":"NCT01558700","phase":"PHASE4","title":"Duloxetine in Osteoarthritis (OA) Pain","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2012-03","conditions":"Osteoarthritis","enrollment":40},{"nctId":"NCT01650740","phase":"NA","title":"Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder","status":"TERMINATED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2012-08","conditions":"Major Depressive Disorder","enrollment":1},{"nctId":"NCT01179672","phase":"PHASE3","title":"A Study in Participants With Diabetic Peripheral Neuropathic Pain in China","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-04","conditions":"Diabetic Neuropathy, Painful","enrollment":405},{"nctId":"NCT01117857","phase":"PHASE4","title":"Duloxetine for Menopausal Depression","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-08","conditions":"Depression, Menopause, Vasomotor Symptoms","enrollment":29}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Sugar pill"],"phase":"marketed","status":"active","brandName":"Placebo (for Duloxetine)","genericName":"Placebo (for Duloxetine)","companyName":"University of Nottingham","companyId":"university-of-nottingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces no pharmacological effect and serves as an inert control in clinical trials to measure the baseline therapeutic response independent of drug action. Used for Control arm in Duloxetine clinical trials (depression, anxiety, chronic pain, fibromyalgia, diabetic peripheral neuropathic pain).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}